Dmitriy Nikolavsky, MD
Urology · Syracuse, NYNPI 1144435041
Payments from drug & device makers
Across 12 payments — averaging $594.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Uromedica, Incorporated$6K
- LSI Solutions Inc$486
- Boston Scientific$218
- Coloplast$163
- Innovation Technologies Inc$123
- Urogen Pharma, Inc.$39
- plus $23 from 1 others
What the payments were for
- Speaking & faculty fees$2,50035%
- Travel & lodging$3,57750%
- Food & beverage$1,05215%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Uromedica, Incorporated | 2 | $6,077 |
| LSI Solutions Inc | 2 | $486 |
| Boston Scientific | 4 | $218 |
| Coloplast | 1 | $163 |
| Innovation Technologies Inc | 1 | $123 |
| Urogen Pharma, Inc. | 1 | $39 |
| Astellas Pharma Global Development | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ProACT$6,077
- JNW URTRAC$486
- RUNNING DEVICE$486
- TI KNOT$348
- TITAN$163
- Irrisept$123
- AMS AMBICOR$109
How this compares
$7,129 in reported general payments places this provider in the 70th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 82 | $61,082 |
| Mirabegron ErMirabegron | 14 | $5,298 |
| Trospium Chloride ErTrospium Chloride | 32 | $4,435 |
| Tolterodine Tartrate ErTolterodine Tartrate | 23 | $2,822 |
| Oxybutynin Chloride ErOxybutynin Chloride | 107 | $1,704 |
| Tamsulosin Hcl | 91 | $1,189 |
| Oxybutynin Chloride | 53 | $882 |
| Finasteride | 58 | $580 |
| Trospium Chloride | 15 | $526 |
| Gentamicin Sulfate | 21 | $469 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $255 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 63 | $166 |
| Sodium ChlorideSodium Chloride Irrig Solution | 24 | $115 |
| Solifenacin Succinate | 15 | $90 |
| Cephalexin | 30 | $89 |
Paid to pharmacies, not to this prescriber.
Other urology in Syracuse
- Christopher PieczonkaSyracuse$31.2M
- Gennady BratslavskySyracuse$2.5M
- Joseph JacobSyracuse$1M
- David AlbalaSyracuse$640K
- Po LamSyracuse$579K
- Guarionex DecastroNew York$5.7M
- Mitchell EfrosGarden City$4.2M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Jed KaminetskyMiddle Village$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.